Pharmaceutical

Bayer settles a small fraction of Yaz, Yasmin lawsuits

bayer logo 100x100 Bayer settles a small fraction of Yaz, Yasmin lawsuits has agreed to settle about 70 of the approximately 11,300 against the giant involving its blockbuster Yaz and , according to the company’s 2011 annual report. The terms of the settlement were not disclosed, but Bayer reportedly said the conditions were reasonable.

The lawsuits were filed on behalf of plaintiffs who allege that using the oral contraceptives, as well as their equivalents and Gianvi, caused them or a loved one or . The birth control pills contain the hormone drospirenone which recent studies have found put women at greater risk for blood clots than oral contraceptives containing older hormones.

The Yaz and Yasmin lawsuits allege that Bayer’s drospirenone-containing pills can cause heart attacks, strokes, pulmonary embolism as well as gallbladder damage, and that the drug company failed to warn users of those risks. Despite the studies, Bayer argued its pills were no more dangerous than other birth control pills.

The pending cases in federal court have been consolidated in multidistrict litigation in Illinois. Last May, the MDL judge denied a class certification. The first bellwether Yaz and Yasmin trials were scheduled to begin in September 2011, but the MDL judge stayed the first case and ordered the parties to mediation.

Bayer’s annual report says it expects more Yaz and Yasmin lawsuits, and will continue to “defend itself vigorously against all that are not considered for settlement.”

Source: Lawyers USA